Explained herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medication, such devices such as a syringe by having an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very low permeability to oxygen and comprises ethy